to make an"authorized generic" version of Humalog that carries a list price of roughly half the branded version at $137 a vial. It's a big move from the drugmaker in the hopes to make insulin more affordable at a time when many are struggling with high out of pocket costs for the lifesaving drug.
I spoke to Laura Marston, who has been living with type 1 diabetes for decades. She remembers what it was like to pay that exact price back in 2012. I also got some insight into why Lilly chose to go the authorized generic route, and why the company picked that particular price tag. Laura Marston holds up a vial of Humalog, a type of insulin she takes for type 1 diabetes at her home in Washington, DC September 27, 2016. When she was first diagnosed at 14, the list price for the drug was $21 per vialA drugmaker just slashed the price of its life-saving medication by 50%, but people are worried the $137 price tag is still unaffordable
On Monday, diabetes drugmaker Eli Lilly said it plans to make an"authorized generic" version of its life-saving diabetes medication Humalog and sell it for half the price of the branded version at $137.35 a vial. Humalog is a type of short-acting insulin, which helps people with diabetes process the sugar in their blood. Its list price has risen more than 1200% since it was first approved in 1996 to $274.70 a vial.And in diabetes-related news,